Cleopatra Hospitals Group S.A.E.

CASE:CLHO Stock Report

Market Cap: ج.م11.5b

Cleopatra Hospitals GroupE Valuation

Is CLHO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CLHO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CLHO (EGP7.94) is trading below our estimate of fair value (EGP8.42)

Significantly Below Fair Value: CLHO is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLHO?

Key metric: As CLHO is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CLHO. This is calculated by dividing CLHO's market cap by their current earnings.
What is CLHO's PE Ratio?
PE Ratio21.2x
Earningsج.م541.02m
Market Capج.م11.48b

Price to Earnings Ratio vs Peers

How does CLHO's PE Ratio compare to its peers?

The above table shows the PE ratio for CLHO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average56.7x
NINH Nozha International Hospital
18.3xn/aج.م1.9b
AMES Alexandria New Medical Center
186.4xn/aج.م2.4b
ISPH Ibnsina Pharma
18x28.1%ج.م6.5b
TNZTP Tapdi Oksijen Özel Saglik ve Egitim Hizmetleri Sanayi Ticaret
3.9xn/a₺7.3b
CLHO Cleopatra Hospitals GroupE
21.2x30.7%ج.م11.5b

Price-To-Earnings vs Peers: CLHO is good value based on its Price-To-Earnings Ratio (21.2x) compared to the peer average (56.7x).

Price to Earnings Ratio vs Industry

How does CLHO's PE Ratio compare vs other companies in the Global Healthcare Industry?

14 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CLHO 21.2xIndustry Avg. 20.6xNo. of Companies72PE01632486480+
14 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CLHO is expensive based on its Price-To-Earnings Ratio (21.2x) compared to the Global Healthcare industry average (20.3x).

Price to Earnings Ratio vs Fair Ratio

What is CLHO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLHO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio21.2x
Fair PE Ratio18.9x

Price-To-Earnings vs Fair Ratio: CLHO is expensive based on its Price-To-Earnings Ratio (21.2x) compared to the estimated Fair Price-To-Earnings Ratio (18.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CLHO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentج.م7.94
ج.م9.50
+19.6%
20.3%ج.م12.00ج.م6.89n/a5
Dec ’25ج.م8.37
ج.م9.50
+13.5%
20.3%ج.م12.00ج.م6.89n/a5
Nov ’25ج.م8.25
ج.م9.50
+15.1%
20.3%ج.م12.00ج.م6.89n/a5
Oct ’25ج.م7.58
ج.م8.87
+17.1%
18.5%ج.م11.40ج.م6.89n/a4
Sep ’25ج.م6.59
ج.م8.83
+34.0%
21.5%ج.م11.40ج.م6.89n/a3
Aug ’25ج.م7.07
ج.م8.56
+21.0%
20.5%ج.م11.40ج.م6.62n/a4
Jul ’25ج.م7.39
ج.م7.61
+2.9%
9.2%ج.م8.20ج.م6.62n/a3
Jun ’25ج.م6.46
ج.م7.54
+16.7%
8.6%ج.م8.00ج.م6.62n/a3
May ’25ج.م6.12
ج.م7.54
+23.2%
8.6%ج.م8.00ج.م6.62n/a3
Apr ’25ج.م6.96
ج.م7.14
+2.6%
8.6%ج.م8.00ج.م6.62n/a3
Mar ’25ج.م6.03
ج.م7.14
+18.4%
8.6%ج.م8.00ج.م6.62n/a3
Feb ’25ج.م4.99
ج.م6.98
+39.9%
8.6%ج.م8.00ج.م6.50n/a4
Jan ’25ج.م4.72
ج.م6.06
+28.4%
11.7%ج.م6.62ج.م5.06n/a3
Dec ’24ج.م5.10
ج.م6.06
+18.8%
11.7%ج.م6.62ج.م5.06ج.م8.373
Nov ’24ج.م4.23
ج.م6.06
+43.3%
11.7%ج.م6.62ج.م5.06ج.م8.253
Oct ’24ج.م3.87
ج.م6.06
+56.6%
11.7%ج.م6.62ج.م5.06ج.م7.583
Sep ’24ج.م3.84
ج.م6.17
+60.8%
13.1%ج.م6.96ج.م5.06ج.م6.593
Aug ’24ج.م3.98
ج.م6.36
+59.7%
12.1%ج.م6.96ج.م5.06ج.م7.074
Jul ’24ج.م4.45
ج.م6.38
+43.3%
11.5%ج.م6.96ج.م5.15ج.م7.394
Jun ’24ج.م4.58
ج.م6.38
+39.3%
10.2%ج.م6.96ج.م5.15ج.م6.465
May ’24ج.م4.50
ج.م6.38
+41.8%
10.2%ج.م6.96ج.م5.15ج.م6.125
Apr ’24ج.م4.41
ج.م6.25
+41.8%
10.7%ج.م6.96ج.م5.15ج.م6.964
Mar ’24ج.م5.30
ج.م6.22
+17.3%
11.8%ج.م6.96ج.م5.00ج.م6.034
Feb ’24ج.م5.62
ج.م6.22
+10.6%
11.8%ج.م6.96ج.م5.00ج.م4.994
Jan ’24ج.م5.32
ج.م6.22
+16.8%
11.8%ج.م6.96ج.م5.00ج.م4.724
Dec ’23ج.م4.40
ج.م6.15
+39.8%
11.6%ج.م6.96ج.م5.00ج.م5.104

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 06:52
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cleopatra Hospitals Group S.A.E. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ahmed RashadBeltone Financial
Alia El MehelmyCI Capital Research
Marina MikhailCI Capital Research